Hybrid in-person and virtual clinic for women with full-spectrum care including perimenopause and HRT.
Insurance-covered telehealth platform specializing in perimenopause and menopause care for women 35+.
Integrative PCOS platform combining endocrinology, dietitian visits, and mental health support.
OB/GYN-led menopause care platform. NAMS-certified clinicians, optional dietitian, and a virtual health coach. Insurance accepted in many states.
Comprehensive PCOS and hormonal health telehealth. Multidisciplinary care team including endocrinologists, dietitians, and mental health professionals.
Calibrate’s insurance-billing arm for women whose employer plan covers Wegovy or Zepbound.
Weight-inclusive primary care with GLP-1 access. Designed by clinicians frustrated with typical obesity medicine model — focuses on the whole person.
Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.
App + coaching menopause platform with a focus on behavioral support. Stasis is the app product; US clinical service available in select states.
Cash-pay menopause telehealth offering bioidentical HRT (compounded and FDA-approved). Subscription with medications shipped monthly.
Women-led birth control and women's health telehealth that includes PCOS-relevant care (hormonal birth control, spironolactone, metformin where appropriate).
Async PCOS prescribing for acne, hirsutism, and irregular cycles. Affordable monthly plans.
Comprehensive midlife women's health platform. Care team includes menopause-trained clinicians plus a community membership component.
App-based menopause care with clinician access and lifestyle coaching. Originally UK-based, expanding US presence.
Hormone testing and replacement platform expanded to women’s HRT in 2024. At-home lab kits + clinician follow-up.
Personalized menopause care with FDA-approved hormonal and non-hormonal options. Async chat with clinicians, medications shipped to your door.
Cash-pay menopause telehealth with FDA-approved HRT delivered monthly. Co-founded by Healthline ex-CEO.
Reproductive health platform with PCOS-friendly fertility prep, ovulation tracking, and Rx coordination.
Hers launched menopause vertical in 2024. Async-first HRT with focus on affordability and speed.
Direct-to-consumer menopause subscription with FDA-approved HRT, optional coaching, and a focus on the perimenopause-to-postmenopause transition.
PCOS-focused care platform combining clinician access with personalized supplement protocols. Subscription model with medication and supplement bundling.
Menopause-focused brand expanded in 2024 from OTC products to telehealth HRT prescribing.
Direct-to-clinician marketplace where users find providers willing to prescribe compounded semaglutide.
Doctor-led GLP-1 weight loss program. Offers compounded semaglutide/tirzepatide and FDA-approved Wegovy/Zepbound for eligible patients.
Hims & Hers' weight loss division offering compounded GLP-1s plus FDA-approved options. Among the most affordable starting prices.
GLP-1-focused DTC platform offering compounded semaglutide and tirzepatide with monthly delivery.
Optimization-focused telehealth offering HRT, TRT, and peptide therapy. Comprehensive lab work upfront.
WW’s clinical arm (formerly Sequence) prescribing GLP-1s integrated with the WW behavior program.
WeightWatchers-acquired clinical weight loss program. Connects you with board-certified clinicians who can prescribe FDA-approved GLP-1s.
PCOS-focused platform with phenotype-driven treatment matching. Specialist providers only.